Ozempic and other weight loss jabs have been linked to ten deaths in Britain. According to the medicine watchdog, there have been about 7,228 reports of drug-related illnesses, including nausea, vomiting and diarrhea, according to experts.

The Healthcare Products Regulatory Agency, or MHRA, said at least 68 patients were admitted to hospitals because of their serious symptoms after the exclusive use of Vegovi and Ozempic – the miracle weight loss pills designed to manage type 2 diabetes. Known as jabs.

Doctors say weight loss drugs have life-threatening side effects

The reports come just months after a doctor publicly warned of possible deaths caused by glucagon-like peptide-1 receptor agonists (GLP-1RAs) after a young girl suffered life-threatening symptoms. Was taken to hospital with.

However, experts say the reports do not prove that these weight loss drugs are solely responsible for each individual case. But they highlight cases where GLP-1RAs have been cast into doubt.

MHRA casts doubt on weight loss drugsbut be careful

The MHRA has reiterated that many reports of deaths may simply be unfortunate coincidences. However, the agency acknowledges that the drugs are associated with unpleasant and widespread side effects.

Last week, the health body instructed doctors to “inform patients about common and serious side effects associated with GLP-1RAs” and “report cases of misuse”. About 50 percent of hospitalizations are linked to the drugs, according to official estimates, with the latest data estimating a 48 percent increase in reports over the past two months.

Any unauthorized use of Ozempic, Wegovi is not permitted

Since the findings of deaths and hospitalizations came to light, the MHRA has reiterated that drugs like Ozempic and Vegovy should not be used for unauthorized indications such as aesthetic weight loss.

It has also warned about the potential black market of medicines, issuing advice to patients to ensure they are prescribed by a registered professional.

UK Health Secretary Wes Streeting previously issued a warning that GLP-1RAs are not cosmetic treatments – and should only be used in exceptional circumstances. “Weight loss drugs have a lot of potential. When taken with a healthy diet and exercise, they can be game changers in tackling obesity and getting people back to good health. But these are not cosmetic drugs that should be “These are serious medications and should only be used responsibly and under medical supervision.”

Last month, Streeting also defended plans to launch a weight loss scheme among unemployed people in a bid to kickstart a major back-to-work drive.

What are GLP-1RAs and how do they work,

According to experts, GLP-1 RAs are suitable for early use in type 2 diabetes, as they stimulate insulin release and suppress glucagon secretion only when blood sugar levels become elevated, reducing the risk of hypoglycemia. Is.

As glucose levels decrease, the effect of GLP-1 RA on insulin secretion also decreases.

Doctors say the drug increases levels of incretins – hormones that are naturally produced in the stomach when you eat. It works by helping your body produce more insulin when it is needed. It also reduces the amount of glucose or sugar produced by the liver and slows down how quickly food is digested. All this helps in reducing blood sugar levels and hbA1c.

This medicine may also reduce the risk of heart disease and stroke.

While Ozempic is only prescribed for people who have a body mass index of 35 kg/m2 or more and have additional psychological or other medical conditions that are related to obesity, many people are taking it otherwise as well.

Get the latest news live on Times Now with breaking news and top headlines from around the world.